Quest Diagnostics (DGX)
NYSE: DGX
· Real-Time Price · USD
180.15
0.64 (0.36%)
At close: Sep 04, 2025, 3:59 PM
178.00
-1.19%
After-hours: Sep 04, 2025, 05:36 PM EDT
0.36% (1D)
| Bid | 178 |
| Market Cap | 20.14B |
| Revenue (ttm) | 10.52B |
| Net Income (ttm) | 949M |
| EPS (ttm) | 8.35 |
| PE Ratio (ttm) | 21.57 |
| Forward PE | 17.26 |
| Analyst | Hold |
| Ask | 182.34 |
| Volume | 465,345 |
| Avg. Volume (20D) | 1,010,970 |
| Open | 180.54 |
| Previous Close | 179.51 |
| Day's Range | 179.38 - 180.84 |
| 52-Week Range | 146.17 - 185.62 |
| Beta | 0.46 |
Analyst Forecast
According to 0 analyst ratings, the average rating for DGX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Quest Diagnostics is scheduled to release its earnings on
Oct 21, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 months ago
+6.78%
Quest Diagnostics shares are trading higher follow...
Unlock content with
Pro Subscription
5 months ago
-2.57%
Quest Diagnostics shares are trading lower after the company issued Q1 revenue and EPS guidance below estimates.
2 weeks ago · https://www.marketscreener.com
Eleventh Circuit Upholds Dismissal Of Qui Tam FCA Suit For Failure To Meet Rule 9(b) SpecificityOverviewIn a qui tam action filed under the False Claims Act, the relator, Barbara Senters, appealed the district court's dismissal of her fourth amended complaint (FAC), which alleged that Quest Diag...
